{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-305467","form_type":"8-K","ticker":"CRDF","cik":"0001213037","company_name":"Cardiff Oncology, Inc.","filed_at":"2026-07-16T12:38:12+00:00","discovered_at":"2026-07-16T12:40:31.318899+00:00","generated_at":"2026-07-16T12:40:36.513643+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Cardiff Oncology raises ~$10M in registered direct offering of common stock and warrants","bullets":["Sold 8,571,429 shares at $1.05/share with warrants for 8,571,429 shares at $1.31 exercise price.","Insiders purchased 731,707 shares at $1.435/share with warrants; total gross proceeds ~$10M.","Warrants exercisable after six months and authorized share increase; expire 5.5 years from start.","Net proceeds to be used for working capital and general corporate purposes.","H.C. Wainwright acted as exclusive placement agent; closing expected July 16, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-305467","json":"https://secwatch.observer/filing/0001193125-26-305467.json","markdown":"https://secwatch.observer/filing/0001193125-26-305467.md","text":"https://secwatch.observer/filing/0001193125-26-305467.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1213037/000119312526305467/0001193125-26-305467-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1213037/000119312526305467/crdf-20260714.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-16T12:40:36.513643+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}